Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors

Pain

Volumn 72, Issue 1-2, 1997, Pages 253-260

  Laughlin, T M ^a   Vanderah, T W ^a   Lashbrook, J ^a   Nichols, M L ^a   Ossipov, M ^a   Porreca, F ^a   Wilcox, G L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allodynia; Dynorphin A; NMDA; Spinal cord

Indexed keywords

DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; DYNORPHIN A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NERVE; PRIORITY JOURNAL; SPINAL CORD;

EID: 0030879183     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00046-8     Document Type: Article

References (53)

1. Aanonsen, L.M. and Wilcox, G.L., Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and σ agonists, J. Pharmacol. Exp. Ther., 243 (1987) 9–19.
2. Bakshi, R. and Faden, A.I., Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis, Brain Res., 507 (1990) 1–5.
3. Bakshi, R., Ni, R.X. and Faden, A.I., N -methyl- d -aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies, Brain Res., 580 (1992) 255–264.
4. Brauneis, U., Peoples, R.W., Oz, M., Weight, F.F. and Zhang, L., Potentiation of NMDA receptor-mediated responses by dynorphin at low glycine, Soc. Neurosci. Abstr., 22 (1996) 67.
5. Carlton, S.M. and Hargett, G.L., Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats, Neurosci. Lett., 198 (1995) 115–118.
6. Caudle, R.M. and Isaac, L., Intrathecal dynorphin (1-13) results in an irreversible loss of the tail-flick reflex in rats, Brain Res., 435 (1987) 1–6.
7. Caudle, R.M. and Isaac, L., Influence of dynorphin (1-13) on spinal reflexes in the rat, J. Pharmacol. Exp. Ther., 246 (1988a) 508–513.
8. Caudle, R.M. and Isaac, L., A novel interaction between dynorphin (1-13) and an N -methyl- d -aspartate site, Brain Res., 443 (1988b) 329–332.
9. Chen, L., Gu, Y. and Huang, L.Y., The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin, J. Neurosci., 15 (1995) 4602–4611.
10. Choi, Y., Yoon, Y.W., Na, H.S., Kim, S.H. and Chung, J.M., Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain, Pain, 59 (1994) 369–376.
11. Cox, B.M., Molineaux, C.J., Jacobs, T.P., Rosenberger, J.G. and Faden, A.I., Effects of traumatic injury on dynorphin immunoreactivity in spinal cord, Neuropeptides, 5 (1985) 571–574.
12. Davies, S.N. and Lodge, D., Evidence for involvement of N -methylaspartate receptors in `wind-up' of class 2 neurons in the dorsal horn of the rat, Brain Res., 424 (1987) 402–406.
13. Dickenson, A.H. and Sullivan, A.F., Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fiber stimulation, Neuropharmacology, 26 (1987) 1235–1238.
14. Dubner, R. and Ruda, M.A., Activity-dependent neuronal plasticity following tissue injury and inflammation, Trends Neurosci., 15 (1992) 96–103.
15. Faden, A.I., Opioid and non-opioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury, Ann. Neurol., 27 (1990) 67–74.
16. Faden, A.I., Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism, J. Neurosci., 12 (1992) 425–429.
17. Faden, A.I. and Jacobs, T.P., Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action, Br. J. Pharmacol., 81 (1984) 271–276.
18. Faden, A.I., Molineaux, C.J., Rosenberger, J.G., Jacobs, T.P. and Cox, B.M., Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury, Ann. Neurol., 17 (1985) 386–390.
19. Haley, J.E. and Wilcox, G.L., Involvement of excitatory amino acids and peptides in the spinal mechanisms underlying hyperalgesia. In: W.D. Willis (Ed.), Hyperalgesia and Allodynia, Raven Press, New York, 1992, pp. 281–293.
20. Hao, J.X., Xu, X.J., Aldskogius, H., Seiger, A. and Wiesenfeld-Hallin, Z., Allodynia-like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation, Pain, 45 (1991) 175–185.
21. Hu, W.H., Lee, F.C., Wan, X., Chen, Y.T. and Jen, M.F., Dynorphin neurotoxicity induced nitric oxide synthase expression in ventral horn cells of rat spinal cord, Neurosci. Lett., 203 (1996) 13–16.
22. Hylden, J.L.K. and Wilcox, G.L., Intrathecal morphine in mice: a new technique, Eur. J. Pharmacol., 67 (1980) 313–316.
23. Hylden, J.L., Nahin, R.L., Traub, R.J. and Dubner, R., Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons, Pain, 44 (1991) 187–193.
24. Iadarola, M.J., Brady, L.S., Draisci, G. and Dubner, R., Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding, Pain, 35 (1988) 313–326.
25. Kajander, K.C., Sahara, Y., Iadarola, M.J. and Bennett, G.J., Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy, Peptides, 11 (1990) 719–728.
26. Knox, R.J. and Dickenson, A.H., Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones, Brain Res., 415 (1987) 21–29.
27. Long, J.B. and Skolnick, P., 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury, Eur. J. Pharmacol., 261 (1994) 295–301.
28. 3-13 reduce rat spinal cord blood flow by non-opioid mechanisms, Brain Res., 436 (1987) 374–379.
29. Long, J.B., Petras, J.M., Mobley, W.C. and Holaday, J.W., Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Non-opioid mechanisms mediate loss of motor, sensory and autonomic function, J. Pharmacol. Exp. Ther., 246 (1988) 1167–1174.
30. Long, J.B., Rigamonti, D.D., Oleshansky, M.A., Wingfield, C.P. and Martinez-Arizala, A., Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury, J. Pharmacol. Exp. Ther., 269 (1994) 358–366.
31. Ma, Q.P. and Woolf, C.J., Noxious stimuli induce an N -methyl- d -aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia, Pain, 61 (1995) 383–390.
32. Magnuson, D.S. and Dickenson, A.H., Lamina-specific effects of morphine and naloxone in dorsal horn of rat spinal cord in vitro, J. Neurophysiol., 66 (1991) 1941–1950.
33. Mao, J., Price, D.D., Hayes, R.L., Lu, J. and Mayer, D.J., Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy, Brain Res., 598 (1992) 271–278.
34. Massardier, D. and Hunt, P.F., A direct non-opiate interaction of dynorphin-(1-13) with the N -methyl- d -aspartate (NMDA) receptor, Eur. J. Pharmacol., 170 (1989) 125–126.
35. Miller, K.E. and Seybold, V.S., Comparison of met-enkephalin, dynorphin A, and neurotensin immunoreactive neurons in the cat and rat spinal cords: II. Segmental differences in the marginal zone, J. Comp. Neurol., 279 (1989) 619–628.
36. Randic, M., Cheng, G. and Kojic, L., k-Opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord, J. Neurosci., 15 (1995) 6809–6826.
37. Ren, K. and Dubner, R., NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw, Neurosci. Lett., 163 (1993) 22–26.
38. Ren, K., Hylden, J.L., Williams, G.M., Ruda, M.A. and Dubner, R., The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation, Pain, 50 (1992) 331–344.
39. Ruda, M.A., Iadarola, M.J., Cohen, L.V. and Young, W., In situ hybridization, histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia, Proc. Natl. Acad. Sci. USA, 85 (1988) 622–626.
40. Seltzer, Z., Cohn, S., Ginzburg, R. and Beilin, B., Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge, Pain, 45 (1991) 69–75.
41. Sherman, S.E. and Loomis, C.W., Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat, Pain, 56 (1994) 17–29.
42. Shukla, V.K. and Lemaire, S., Non-opioid effects of dynorphins: possible role of the NMDA receptor, Trends Pharmacol. Sci., 15 (1994) 420–424.
43. Skilling, S.R., Sun, X., Kurtz, H.J. and Larson, A.A., Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity, Brain Res., 575 (1992) 272–278.
44. Stevens, C.W. and Yaksh, T.L., Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity, J. Pharmacol. Exp. Ther., 238 (1986) 833–838.
45. Stewart, P. and Isaac, L., Dynorphin-induced depression of the dorsal root potential in rat spinal cord: a possible mechanism for potentiation of the C-fiber reflex, J. Pharmacol. Exp. Ther., 259 (1991) 608–613.
46. Thornhill, J.A., Gregor, L., Mathison, R. and Pittman, Q., Intrathecal dynorphin A administration causes pressor responses in rats associated with an increased resistance to spinal cord blood flow, Brain Res., 490 (1989) 174–177.
47. Vanderah, T.W., Laughlin, T., Lashbrook, J.M., Nichols, M.L., Wilcox, G.L., Ossipov, M.H., Malan, T.P. and Porreca, F., Single intrathecal injections of dynorphin A or des -TYR-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone, Pain, 68 (1996) 275–281.
48. Willenbring, S. and Stevens, C.W., Thermal, mechanical and chemical peripheral sensation in amphibians: opioid and adrenergic effects, Life Sci., 58 (1996) 125–133.
49. Woolf, C.J. and Thompson, S.W., The induction and maintenance of central sensitization is dependent on N -methyl- d -aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, 44 (1991) 293–299.
50. Yaksh, T.L., Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonist, Pain, 37 (1989) 111–123.
51. Yaksh, T.L. and Harty, G.J., Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine, J. Pharmacol. Exp. Ther., 244 (1988) 501–507.
52. Yaksh, T.L., Harty, G.J. and Onofrio, B.M., High dose of spinal morphine produces a non-opiate receptor-mediated hyperesthesia: clinical and theoretic implications, Anesthesiology, 64 (1986) 590–597.
53. Yamamoto, T. and Yaksh, T.L, Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801, Pain, 54 (1993) 79–84.